Log in
Enquire now
TargED

TargED

Developer of an antibody-enzyme fusion protein aimed at treating various thrombotic events

OverviewStructured DataIssuesContributors

Contents

targedbiopharmaceuticals.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biomedical engineering
Biomedical engineering
Manufacturing
Manufacturing
Pharmaceutical industry
Pharmaceutical industry
CEO
‌
Kristof Vercruysse
Founder
‌
Marc van Moorsel
‌
Kristof Vercruysse
‌
Steven de Maat
‌
Coen Maas
Pitchbook URL
pitchbook.com/profiles...454383-10
Number of Employees (Ranges)
11 – 50
Investors
Fund+
Fund+
‌
Curie Capital
Hadean Ventures
Hadean Ventures
Sunstone Life Science Ventures
Sunstone Life Science Ventures
Inkef Capital
Inkef Capital
BioGeneration Ventures
BioGeneration Ventures
Andera Partners
Andera Partners
Founded Date
2018
Total Funding Amount (USD)
69,000,000
Latest Funding Round Date
December 16, 2025
Latest Funding Type
Series A
Series A
Country
Netherlands
Netherlands
Headquarters
Utrecht
Utrecht

Other attributes

Latest Funding Round Amount (USD)
25,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like TargED

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.